Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
SELLAS Life Sciences Group ( (SLS) ) has issued an announcement.
On June 17, 2025, SELLAS Life Sciences Group, Inc. held its Annual Meeting of Stockholders, where several key proposals were voted upon. Stockholders re-elected Class III directors, ratified the appointment of Baker Tilly US, LLP as the independent registered public accounting firm, approved an amendment to the 2021 Employee Stock Purchase Plan to increase available shares, and supported a non-binding resolution on executive compensation. Additionally, the frequency of future advisory votes on executive compensation was recommended, and an adjournment of the meeting was approved if necessary to gather more proxies.
The most recent analyst rating on (SLS) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on SELLAS Life Sciences Group stock, see the SLS Stock Forecast page.
Spark’s Take on SLS Stock
According to Spark, TipRanks’ AI Analyst, SLS is a Neutral.
SELLAS Life Sciences Group’s overall stock score is low due to significant financial challenges, including inconsistent revenue, negative profitability, and reliance on external financing. The technical analysis shows strong momentum, but overbought conditions pose near-term risks. Valuation metrics are concerning with a negative P/E ratio and no dividend yield, further impacting the stock’s attractiveness.
To see Spark’s full report on SLS stock, click here.
More about SELLAS Life Sciences Group
SELLAS Life Sciences Group, Inc. operates in the biopharmaceutical industry, focusing on the development of innovative cancer immunotherapies. The company is dedicated to advancing its pipeline of novel treatments aimed at addressing unmet medical needs in oncology.
Average Trading Volume: 2,070,380
Technical Sentiment Signal: Hold
Current Market Cap: $160.6M
See more data about SLS stock on TipRanks’ Stock Analysis page.